Linked Data API

Show Search Form

Search Results

1719284
registered interest false more like this
date less than 2024-05-20more like thismore than 2024-05-20
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Pancreatic Cancer: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps she is taking to help ensure the adequacy of access to (a) Creon and (b) other drugs that contain pancreatic enzymes for patients after pancreatic surgery. more like this
tabling member constituency Broxbourne more like this
tabling member printed
Sir Charles Walker remove filter
uin 26982 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-23more like thismore than 2024-05-23
answer text <p>We are aware of supply issues with three pancreatic enzyme replacement therapies: Creon 10,000 gastro-resistant capsules; Creon 25,000 gastro-resistant capsules; and Nutrizym 22 gastro-resistant capsules. We understand that these are due to limited availability of active pharmaceutical ingredients, and manufacturing constraints in producing the volumes required to meet demand. The Department has issued guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products to ask that they expedite deliveries and increase production forecasts, and to confirm that they are taking action to address the root causes of the issues, to ensure continuity of supply. We are also working with specialist importers to source unlicensed imports from abroad.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
question first answered
less than 2024-05-23T15:24:29.583Zmore like thismore than 2024-05-23T15:24:29.583Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
1493
label Biography information for Sir Charles Walker more like this
1717955
registered interest false more like this
date less than 2024-05-14more like thismore than 2024-05-14
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading NHS: Correspondence more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if she will hold discussions with Royal Mail on the potential merits of treating NHS letters as first class post, in the context of possible reforms to the second class delivery service. more like this
tabling member constituency Broxbourne more like this
tabling member printed
Sir Charles Walker remove filter
uin 26093 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-17more like thismore than 2024-05-17
answer text <p>My Rt hon. Friend, the Secretary of State for Health and Social Care has written to Royal Mail regarding proposed reforms to the universal postal service, to ask what consideration has been given to patients and National Health Service impacts. A meeting with the Group Chief Executive of Royal Mail is currently being considered.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
question first answered
less than 2024-05-17T07:39:59.09Zmore like thismore than 2024-05-17T07:39:59.09Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
1493
label Biography information for Sir Charles Walker more like this
1692165
registered interest false more like this
date less than 2024-02-27more like thismore than 2024-02-27
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Brain: Tumours more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the level of NHS funding for brain tumour research compared to research into other cancers; and if she will provide the quantum of NHS research funding into brain tumours for each of the last five financial years. more like this
tabling member constituency Broxbourne more like this
tabling member printed
Sir Charles Walker remove filter
uin 15848 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-03more like thismore than 2024-04-03
answer text <p>The Department invests over £1 billion per year into health research, through the National Institute for Health Research (NIHR), whose research spending for all cancers was £121.8 million in 2022/23. Funding for the delivery of brain cancer studies in the National Health Service cannot be disaggregated from other studies, but to indicate scale, in 2022/23 the NIHR Clinical Research Network supported 61 brain cancer studies and recruited 4,317 participants to these studies.</p><p>Over the past five financial years, the NIHR has spent over £11.3 million in funding for brain cancer research. The following table shows the amount of funding awarded for brain cancer research, from 2018/19 to 2022/23:</p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Funding amount</p></td></tr><tr><td><p>2018/19</p></td><td><p>£2.9 million</p></td></tr><tr><td><p>2019/20</p></td><td><p>£150,000</p></td></tr><tr><td><p>2020/21</p></td><td><p>£2.2 million</p></td></tr><tr><td><p>2021/22</p></td><td><p>£5.3 million</p></td></tr><tr><td><p>2022/23</p></td><td><p>£750,000</p></td></tr><tr><td><p>Total</p></td><td><p>£11.3 million</p></td></tr></tbody></table><p>Note: the amount of funding awarded will differ to actual spend in a given year, as total spending will include that of multi-year awards made in previous years.</p><p>The NIHR funds research in response to proposals received from scientists, rather than allocating funding to specific disease areas. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.</p><p>To increase the quality, diversity, and number of brain cancer research proposals, the NIHR is working with the Tessa Jowell Brain Cancer Mission and the research community, to develop research capacity in the brain cancer community.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
question first answered
less than 2024-04-03T15:17:18.357Zmore like thismore than 2024-04-03T15:17:18.357Z
answering member
4044
label Biography information for Andrew Stephenson more like this
previous answer version
20891
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
1493
label Biography information for Sir Charles Walker more like this